Logo
x

Search

Subscribe Now

Candidates

Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

  • December 21, 2020
Teva and Alvotech Collaborate to Commercialize Five Biosimilar Candidates in the US

Teva and Alvotech Collaborate to Commercialize Five Biosimilar Candidates in the US

  • August 5, 2020
Mundipharma Collaborates with Samsung Bioepis to Commercialize Multiple Biosimilar Candidates in Hong Kong and Taiwan

Mundipharma Collaborates with Samsung Bioepis to Commercialize Multiple Biosimilar Candidates in Hong Kong and Taiwan

  • January 13, 2020
Evotec Signs an Agreement with Celmatix to Develop Pre-Clinical Candidates for Women Health

Evotec Signs an Agreement with Celmatix to Develop Pre-Clinical Candidates for Women Health

  • October 10, 2019
Janssen(J&J) Signs an Exclusive Worldwide License Agreement with MeiraGTx for its Gene Therapy Candidates

Janssen(J&J) Signs an Exclusive Worldwide License Agreement with MeiraGTx for its Gene Therapy Candidates

  • February 1, 2019
Lilly Collaborates with AC Immune (AC) to Develop Candidates for Neurodegenerative Diseases

Lilly Collaborates with AC Immune (AC) to Develop Candidates for Neurodegenerative Diseases

  • December 13, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.